Cargando…
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
Discoidin domain receptor (DDR) is a collagen-activated receptor tyrosine kinase that plays critical roles in regulating essential cellular processes such as morphogenesis, differentiation, proliferation, adhesion, migration, invasion, and matrix remodeling. As a result, DDR dysregulation has been a...
Autores principales: | Elkamhawy, Ahmed, Lu, Qili, Nada, Hossam, Woo, Jiyu, Quan, Guofeng, Lee, Kyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235339/ https://www.ncbi.nlm.nih.gov/pubmed/34207360 http://dx.doi.org/10.3390/ijms22126535 |
Ejemplares similares
-
Characterization of DDR2 Inhibitors for the Treatment
of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015) -
Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
por: Denny, William A., et al.
Publicado: (2021) -
BMI1, ATM and DDR
por: Lin, Xiaozeng, et al.
Publicado: (2015) -
Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer
por: Nada, Hossam, et al.
Publicado: (2021) -
Discovery of a Potent and Selective DDR1 Receptor
Tyrosine Kinase Inhibitor
por: Kim, Hyung-Gu, et al.
Publicado: (2013)